Funding profile · Life science data infrastructure

Lamin

Four years old, Y Combinator backed, and invisible to the SEC. Every dollar on record for Lamin comes from third party databases rather than filings, and the largest of those numbers is exactly the size of the accelerator cheque.

Data as of September 23, 2026. Company-reported and aggregator-reported figures are labeled.

Rounds at a glance

What the filings show

Reading the filings

1. The only hard total is the size of the YC cheque.PitchBook puts money raised at $500K. Y Combinator’s published standard deal is $500,000, split as $125,000 on a post-money SAFE for 7% and $375,000 on an uncapped MFN SAFE. Dealroom’s separate $125k seed line is the first half of that same cheque. The economical reading of both databases is that neither has seen a priced round, and both are reporting fragments of the accelerator investment.
2. The Delaware parent over a Munich operating company is the accelerator flip.The imprint states that Lamin Labs GmbH is a subsidiary of Lamin Labs Inc in Dover, Delaware. YC’s deal page says it invests in US, Canada, Cayman and Singapore corporations and that a foreign company must flip, after which “the original entity will become a subsidiary of a new parent company”. The corporate structure is the accelerator’s requirement showing up in the German register.
3. Zero Form D does not mean zero money.Securities sold under Section 4(a)(2) require no Form D, and SAFEs sold to accredited investors routinely go unreported this way. What it does mean is that there is no filed, dated, dollar-denominated record of any Lamin financing. Every figure on this page is second hand.
4. The investor list grew and the amounts never did.The archived 2023 about page named four angels: Aaron Kimball of WibiData, Alec Nielsen of Asimov, Jeff Hammerbacher of Cloudera and Oskari Saarenmaa of Aiven, above an unlabelled venture capital block. A 2024 write-up added Pillar VC and Pioneer Fund. PitchBook counts eight investors and names only Dimension. Across four years of accumulating names, not one round size has been published.
5. May 10, 2025 is the only date two databases agree on.Seedtable records a last funding date of May 10, 2025 with the amount blank. Crunchbase indexes a seed round on the same date. Neither carries a figure, and no filing corroborates either.
6. The revenue figure in circulation has no source.One AI generated aggregator asserts $3M revenue and a pre-seed company stage on the same page, which is internally inconsistent. PitchBook leaves revenue blank. Nothing in the public record supports a revenue number.

Commercial signals

What to watch

• A first Form D. It would be due within 15 days of the first sale in a Regulation D offering.
• Any priced round. It would convert the YC SAFEs and fix ownership for the first time.
• Whether Dimension, the only named institutional backer, follows on.
• A named customer with a contract value. The company names large pharma; large pharma has not named the company.
• Headcount. Thirteen people carrying 47 repositories and an enterprise sales motion is the binding constraint.

The Lamin story on Healthcare DiscoveryHealthcare Discovery

Related companies

• Shimmer: Shared investor: Pillar Vc. Weekly one to one ADHD coaching by video, sold straight to consumers
• Medplum: Also in Healthcare IT. An open source, FHIR native electronic health record that developers install instead of licensing
• Tuva Health: Also in Healthcare IT. An open source dbt project that turns raw claims and clinical records into an analytics ready data model inside a health system’s own warehouse
• Cellbyte: Also in Healthcare IT. A Munich AI startup that wants to replace the spreadsheets, consultants and legacy databases pharma companies use to price and launch new drugs

Sources

1. Public recordSEC EDGAR full text search and Form D company search for LaminSEC · run Sep 23, 2026
2. Public recordLamin Labs GmbH imprint, HRB 279584, Amtsgericht München, with Delaware parentlamin.ai · accessed Sep 23, 2026
3. Public recordThe Y Combinator Standard Deal, including the flip requirementY Combinator · accessed Sep 23, 2026
4. Public recordGitHub API record for laminlabs repositoriesGitHub · Sep 23, 2026
5. Public recordPyPI download statistics for lamindb and biontyPyPI · Sep 23, 2026
6. IndependentLamin company profile: valuation, funding and investorsPitchBook · profile dated Aug 2026
7. IndependentLamin company information, funding and investorsDealroom.co · accessed Sep 23, 2026
8. IndependentLamin funding, investors and team, last funding date May 10, 2025Seedtable · updated Jul 29, 2026
9. IndependentLamin: Open Data Platform for Biology Bridges BioTech Gaps, with investor listNewzchain, Divya Thakkar · 2024
10. Peer reviewedscPRINT: pre-training on 50 million cells allows robust gene network predictionsNature Communications 16:3607 · Apr 2025
11. CompanyLamin about page and 2023 archived about page with investor listlamin.ai and Internet Archive
12. CompanyLamin pricing tiers as reproduced in an aggregator profileExtruct · Sep 2026

Compiled from SEC, GitHub, PyPI, Europe PMC and German commercial register records and published reports as of September 23, 2026. No Form D has been filed for this company; amounts shown are aggregator-reported or company-reported and are labeled as such. Healthcare Venture Capital Fund holds no position in Lamin. This page is not an offer to sell or a recommendation to buy any security.